Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2048 of 6351
-
Can a phone app keep you sober? new study tests Anti-Alcohol training
Prevention CompletedThe rate of relapse following an inpatient alcohol rehabilitation program has been around 50% for a number of years. Offered treatments mainly focus on conscious and controllable aspects of behaviour, but research has found that much of the craving in addiction is guided by autom…
Sponsor: Salus Klinik Lindow • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Lung cancer trial aims to uncover secrets of drug resistance
Knowledge-focused OngoingThis is a phase 2 single-arm, non-randomized multicentre and tissue acquisition study to evaluate acquired resistance mechanisms, efficacy, and safety in advanced, EGFR tyrosine kinase inhibitor-naïve NSCLC patients with EGFR-activating mutations who receive a first-line osimerti…
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New combo shows promise for tough bile duct cancer
Disease control CompletedThe purpose of this study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug combination of nivolumab plus nanoliposomal-irinotecan, 5-fluorouracil, and leucovorin for patients with advanced or metastatic biliary tract can…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Muscle therapy may restore strength in dialysis patients
Symptom relief Recruiting nowThis research is being done to better understand the impact of the use of a specific physical activity training program (GH Method) in dialysis/kidney disease patients.
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New drug aims to clear painful hand and foot pustules
Disease control CompletedA study to evaluate the efficacy and safety, and pharmacokinetic (PK) profile of multiple doses of imsidolimab (ANB019) in adults with palmoplantar pustulosis (PPP)
Phase 2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 17:06 UTC
-
New drug combo shows promise for Hard-to-Treat ovarian cancer
Disease control OngoingThe study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.
Phase 2 • Sponsor: Gynecologic Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Once-a-Week needle could replace daily pokes for growth hormone deficiency
Disease control CompletedThe study compares 2 medicines for children who do not have enough hormone to grow: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Researchers will test to see how well somapacitan works. The study wi…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New daily pill shows promise in early breast cancer trial
Disease control CompletedTQB3616 may work in cancer by stopping cancer cells from multiplying.TQB3616 is in a new class of drugs called CDK inhibitors.This research study is the first time that TQB3616 will be given to people.TQB3616 is taken by mouth daily.
Phase 1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for cancer patients when immunotherapy fails?
Disease control CompletedThis is a Phase 1, open-label, first-in-human study of CTX-471 administered as a monotherapy or in combination with pembrolizumab in patients with metastatic or locally advanced malignancies that have progressed while receiving an approved PD-1 or PD-L1 inhibitor. The study will …
Phase 1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a diabetes drug shrink dangerous belly fat in HIV patients?
Disease control OngoingThis is a randomized, double-blinded, placebo-controlled trial designed to assess the effect of the GLP-1 receptor agonist, semaglutide, on visceral and ectopic fat, insulin resistance, inflammation markers, and the downstream effect of cardiovascular risk in people with HIV. The…
Phase 2 • Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental drug combo offers hope for Tough-to-Treat blood cancers
Disease control Recruiting nowThis phase I trial studies best dose and side effects of liposome-encapsulated daunorubicin-cytarabine (CPX-351) and how well it works in treating patients with high risk myelodysplastic syndrome or chronic myelomonocytic leukemia that has come back or has not responded to treatm…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Brain zaps and electric gloves: new hope for stroke survivors with severe hand paralysis?
Disease control OngoingThis study is a necessary and important step in the development of a new therapy for upper limb functional recovery in patients with severe motor impairment. It is the first clinical trial of non-invasive brain stimulation (repetitive transcranial magnetic stimulation or rTMS) de…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Heart transplant patients get new weapon against hidden artery damage
Disease control CompletedThe focus of this study is to test the safety and efficacy of the PCSK9 inhibitor, alirocumab when administered early after heart transplantation (HT).The main objective of this project is to test the safety and impact on cardiac allograft vasculopathy (CAV) of alirocumab when gi…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Smartphone apps may bring skin care to rural veterans
Knowledge-focused CompletedThis study was designed to measure the impact of two teledermatology apps to provide direct to patient teledermatology follow up care, Patient Viewer and My VA Images, with a trial on access to dermatology care. The overall hypothesis was that sites implementing Department of Vet…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can intensive behavioral therapy boost social skills in young children with autism?
Symptom relief CompletedThe purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).
Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Radiation-Free path for Low-Risk breast cancer patients?
Disease control OngoingFollowing breast-conserving surgery (BCS) for localized ductal carcinoma in situ (DCIS) of the breast, whole-breast irradiation (WBRT) is a standard of care, reducing the absolute rate of in-breast recurrences (IBR) by more than 15% at 10 years, from 28% without radiotherapy to 1…
Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a steroid shot before surgery tame leg swelling?
Symptom relief CompletedThe assessment consists in comparing corticoids injection versus placebo in surgery of lower limb fractures The aim of study is to assess (state cutaneous, efficacy, safety) corticoids injection on a prospective, randomized analysis
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
New radiation method aims to improve sarcoma surgery outcomes
Disease control Recruiting nowThe study is a randomized, open, prospective phase II study. The aim of the study is to evaluate the safety and feasibility of a hypofractionated, accelerated radiation approach based on the incidence of grade 3-5 NCI Common Terminology Criteria for Adverse Events (NCI-CTC-AE ) t…
Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Freezing hope: new study aims to protect fertility in transgender youth
Knowledge-focused OngoingThe goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. Optimize techniques for processing and cryopreserving testicular tissue. 2. Determine presence and number of germ cells (sperm pr…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Smart scans could spare lymphoma patients from extra chemo
Knowledge-focused Recruiting nowThe overarching goals of this study are to measure levels of circulating tumor DNA (ctDNA) in patients with early stage diffuse large B cell lymphoma (DLBCL), to assess the change in ctDNA during treatment in order to prospectively identify markers of treatment failure, and to us…
Phase 2 • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC